Clinical Trial Update: Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery [Phase 2]

View source ↗

Summary

Phase 2 study evaluating aqueous humor concentrations of bromfenac in DuraSite (InSite Vision 303) to Bromday once daily before cataract surgery has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• Bromday (bromfenac)
• Bromfenac in DuraSite (InSite Vision 303, ISV 303) (bromfenac in DuraSite)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Cataract | Phase 2 | Status: COMPLETED | Results posted: 2016-06-02